Pediculosis capitis (head lice infestations) occur in all age groups, but especially in elementary school children. In most cases, transmission occurs by head-to-head contact. Pharmacologic treatment is…
Med Lett Drugs Ther. 2024 Jun 10; 66(1704):89-92 doi:10.58347/tml.2024.1704a
Pediculosis capitis (head lice infestations) occur in all age groups, but especially in elementary school children. In most cases, transmission occurs by head-to-head contact. Pharmacologic treatment is recommended for persons with live lice or eggs (nits) within 1 cm of the scalp. Topical pediculicides should be tried first. Oral therapy is occasionally required for refractory infestations.
Topical ivermectin lotion 0.5% (Sklice, and generics), which has been available by prescription since 2012, is now FDA-approved for sale over the counter (OTC) for treatment of head lice in patients ≥6…
Med Lett Drugs Ther. 2023 Jun 26; 65(1679):103-4 doi:10.58347/tml.2023.1679e
Topical ivermectin lotion 0.5% (Sklice, and generics), which has been available by prescription since 2012, is now FDA-approved for sale over the counter (OTC) for treatment of head lice in patients ≥6 months old. Ivermectin is also available by prescription as a 1% cream (Soolantra) approved for topical treatment of inflammatory lesions of rosacea and in oral tablets ( Stromectol , and generics) for treatment of various parasitic infections.
Head lice infestation occurs in all age groups, but especially in elementary school children. In most cases, transmission occurs by head-to-head contact.
Med Lett Drugs Ther. 2016 Nov 21; 58(1508):150-2
Head lice infestation occurs in all age groups, but especially in elementary school children. In most cases, transmission occurs by head-to-head contact.
The FDA has approved the antiparasitic drug ivermectin in a 0.5% lotion ( Sklice – Sanofi Pasteur) as a single-use topical treatment for head lice in patients ≥6 months old. Oral ivermectin ( Stromectol…
Med Lett Drugs Ther. 2012 Aug 6; 54(1396):61-3
The FDA has approved the antiparasitic drug ivermectin in a 0.5% lotion ( Sklice – Sanofi Pasteur) as a single-use topical treatment for head lice in patients ≥6 months old. Oral ivermectin ( Stromectol – Merck) is effective for treatment of head lice resistant to other therapies, but it has not been approved by the FDA for this indication.
The FDA has approved spinosad 0.9% suspension ( Natroba – ParaPro) for topical treatment of head lice infestation in patients ≥4 years old. It is available only by prescription.
Med Lett Drugs Ther. 2011 Jun 27; 53(1367):50-1
The FDA has approved spinosad 0.9% suspension ( Natroba – ParaPro) for topical treatment of head lice infestation in patients ≥4 years old. It is available only by prescription.
The FDA has approved benzyl alcohol lotion, 5% ( Ulesfia Lotion - Sciele) for treatment of head lice in patients ≥6 months old. The active ingredient is 5% benzyl alcohol; the vehicle is 5% mineral oil.
Med Lett Drugs Ther. 2009 Jul 27; 51(1317):57-8
The FDA has approved benzyl alcohol lotion, 5% ( Ulesfia Lotion - Sciele) for treatment of head lice in patients ≥6 months old. The active ingredient is 5% benzyl alcohol; the vehicle is 5% mineral oil.
Head lice occur in all age groups, but especially in elementary school children during the winter months. Infestations are becoming more difficult to treat because of increasing resistance to the chemical…
Med Lett Drugs Ther. 2005 Aug 15; 47(1215):68-70
Head lice occur in all age groups, but especially in elementary school children during the winter months. Infestations are becoming more difficult to treat because of increasing resistance to the chemical pediculicides commonly used, particularly those that are available over-the-counter (OTC).